Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice-Reference-Cited by-同舟云学术

Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice

Published:2016-10 Issue:1 Volume:121 Page:26-31
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Driessen Elisabeth J.M.,Bootsma Gerbern P.,Hendriks Lizza E.L.,van den Berkmortel Franchette W.P.J.,Bogaarts Brigitte A.H.A.,van Loon Judith G.M.,Dingemans Anne-Marie C.,Janssen-Heijnen Maryska L.G.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference40 articles.

1. Progress in standard of care therapy and modest survival benefits in the treatment of Non-small Cell Lung Cancer patients in the Netherlands in the last 20years;van der Drift;J Thorac Oncol,2012

2. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

3. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial;Albain;Lancet,2009

4. Sequential vs concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

5. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer;Eberhardt;Ann Oncol,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcome of definitive radiotherapy for locally advanced non‐small cell lung cancer: A real‐world single‐center study in the pre‐durvalumab era;Cancer Medicine;2024-07-31

2. Outcomes of Multimodal Treatment in Elderly Patients with Localized Non-Small Lung Cancer from a Radiation Oncology Point of View: Special Focus on Low-Dose Cisplatin;Cancers;2024-01-11

3. A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study;European Journal of Cancer;2023-12

4. Effects of exercise prehabilitation and/or rehabilitation on health-related quality of life and fatigue in patients with non-small cell lung cancer undergoing surgery: A systematic review;European Journal of Surgical Oncology;2023-10

5. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation;Clinical Lung Cancer;2023-03